Jeffrey R. Maranian - 02 Jul 2021 Form 3 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
VP, Corporate Controller
Signature
/s/ Jeffrey R. Maranian
Issuer symbol
SMMT
Transactions as of
02 Jul 2021
Net transactions value
$0
Form type
3
Filing time
09 Jul 2021, 16:44:33 UTC
Next filing
15 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SMMT Stock Option (right to buy) 02 Jul 2021 Common Stock 112,500 $4.40 Direct F1
holding SMMT Stock Option (right to buy) 02 Jul 2021 Common Stock 112,500 $4.40 Direct F2
holding SMMT Stock Option (right to buy) 02 Jul 2021 Common Stock 20,000 $6.61 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on November 22, 2020 pursuant to the Issuer's Stock Incentive Plan. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occuring on November 22, 2021.
F2 The option was granted on November 22, 2020 pursuant to the Issuer's Stock Incentive Plan. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occuring on November 22, 2021, subject to the satisfaction of certain performance targets.
F3 The option was granted on June 16, 2021 pursuant to the Issuer's Stock Incentive Plan. The shares underlying the option are scheduled to vest in two equal annual installments, with the first such installment occuring on June 1, 2022.